Abstract
Lewy bodies, a defining pathological characteristic of Parkinson's disease and dementia with Lewy bodies (DLB)1,2,3,4, constitute the second most common nerve cell pathology, after the neurofibrillary lesions of Alzheimer's disease. Their formation may cause neurodegeneration, but their biochemical composition is unknown. Neurofilaments and ubiquitin are present5,6,7,8, but it is unclear whether they are major components of the filamentous material of the Lewy body9,10. Here we describe strong staining of Lewy bodies from idiopathic Parkinson's disease with antibodies for α-synuclein, a presynaptic protein of unknown function which is mutated in some familial cases of the disease11. α-Synuclein may be the main component of the Lewy body in Parkinson's disease. We also show staining for α-synuclein of Lewy bodies from DLB, indicating that the Lewy bodies from these two diseases may have identical compositions.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
196,21 € per year
only 3,85 € per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout


References
Lewy,, F. H. in Handbuch der Neurologie Band III (ed. Lewandowski, M.) 920–933 (Springer, Berlin, 1912).
Trétiakoff, M. C. Thesis, Univ. Paris (1919).
Okazaki, H., Lipkin, L. E. & Aronson, S. M. J. Neuropathol. Exp. Neurol. 20, 237–244 (1961).
Kosaka, K., Oyanagi, S., Matsushita, M., Hori, A. & Iwase, S. Acta Neuropathol. 36, 221–233 (1976).
Goldman, J. E., Yen, S. -H., Chiu, F. -C. & Peress, N. S. Science 221, 1082–1084 (1983).
Schmidt, M. L.et al. Am. J. Pathol. 139, 53–65 (1991).
Kuzuhara, S., Mori, H., Izumiyama, N., Yoshimura, M. & Ihara, Y. Acta Neuropathol. 75, 345–353 (1988).
Lennox, G., Lowe, J., Morrell, K., Landon, M. & Mayer, R. J. J. Neurol. Neurosurg. Psychiat. 52, 67–71 (1989).
Duffy, P. E. & Tennyson, V. M. J. Neuropathol. Exp. Neurol. 24, 398–414 (1965).
Roy, S. & Wolman, L. J. Pathol. 99, 39–44 (1969).
Polymeropoulos, R.et al. Science 276, 2045–2047 (1997).
Jakes, R., Spillantini, M. G. & Goedert, M. FEBS Lett. 345, 27–32 (1994).
Shaw, G. & Chau, V. Proc. Natl Acad. Sci. USA 85, 2854–2858 (1988).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Spillantini, M., Schmidt, M., Lee, VY. et al. α-Synuclein in Lewy bodies. Nature 388, 839–840 (1997). https://doi.org/10.1038/42166
Issue Date:
DOI: https://doi.org/10.1038/42166
This article is cited by
-
Current progression in application of extracellular vesicles in central nervous system diseases
European Journal of Medical Research (2024)
-
The involvement of α-synucleinopathy in the disruption of microglial homeostasis contributes to the pathogenesis of Parkinson’s disease
Cell Communication and Signaling (2024)
-
Mutant α-synuclein causes death of human cortical neurons via ERK1/2 and JNK activation
Molecular Brain (2024)
-
Human serum-derived α-synuclein auto-antibodies mediate NMDA receptor-dependent degeneration of CNS neurons
Journal of Neuroinflammation (2024)
-
Unravelling cell type-specific responses to Parkinson’s Disease at single cell resolution
Molecular Neurodegeneration (2024)